Research shows that SphK2 increases TXNIP, NLRP3 inflammasome and IL-1β levels, induces inflammation, promotes renal tubular epithelial cell damage, leading to DKD aggravation (24). This evidence concerns the gene NLRP3 and diabetic kidney disease.